SINGLE ARTERIAL ACCESS FOR TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION WITH THE ACURATE NEO SELF-EXPANDING AORTIC BIOPROSTHESIS: INSIGHTS FROM THE LONDON HEALTH SCIENCES CENTRE HEART TEAM

BackgroundRefinements in transcatheter aortic valve technologies have led to a reduction delivery systems profiles and, along with expandable introducer sheaths, reducing the incidence of vascular complications. Nonetheless, second arterial access is needed landmark cusps while obtaining coplanar view. We aimed report our single-center experience using single-arterial for implantation (TAVI) Acurate neo (Boston Scientific, Marlborough, USA) self-expanding bioprosthesis.Methods and ResultsTAVI system was performed by transfemoral hybrid operating room. Femoral obtained fluoroscopy ultrasound guided two suture-mediated Perclose ProGlide (Abbott Laboratories, Chicago, IL, devices were deployed preclosure technique. A 14-French iSleeve sheath then inserted. The hemostatic punctured at 2 o’clock (close outer edge, Figure) an 18G needle, 0.035” J-type wire advanced, 5-French pigtail inserted over-the-wire. Balloon valvuloplasty all patients rapid pacing over Safari preshaped wire. Afterwards, advanced TAVI as per standard practice. Outcomes assessed according valvular academic research consortium (VARC-3) criteria 30 days. total 100 (mean age 85±6 years, 60% women) included. Procedures successfully patients. There no conversions surgery, (2%) surgical repairs femoral artery. One (1%) patient had in-hospital stroke. Length hospital stay 1.4±1.6 Six (out 93 [6.5%] without prior pacemaker) required new permanent pacemaker implantation, there deaths days.Conclusion bioprosthesis. Refinements Methods Conclusion